BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Thursday reported a loss of $5.2 million in its first quarter.
The Beverly Hills, California-based company said it had a loss of 23 cents per share.
The biotechnology company posted revenue of $40,800 in the period. Its adjusted revenue was $41,000.
In the final minutes of trading on Thursday, the company's shares hit $3.16. A year ago, they were trading at $6.66.
The Associated Press